GNMXvsGNOMETF Comparison
VS
Corgi Genomics & Precision Medicine ETF (GNMX) and Global X Genomics & Biotechnology ETF (GNOM) belong to the same industry segment: BioTech & Genomics. GNMX's top 1 sector exposures are Healthcare. GNMX is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.5% for GNOM. Run a side-by-side ETF comparison of GNMX and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
GNMX vs GNOM performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/10/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | GNMX GNOM | +4.88%+4.00% | +30.11%+29.53% | n/a+36.18% | n/a+71.82% | n/a+43.07% | n/a-34.23% |
| Flows | GNMX GNOM | +$1M-$688K | +$761K+$15M | -+$17M | -+$12M | --$57M | --$45M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | GNMX GNOM | +33.25%+38.04% | n/a+30.59% | n/a+30.38% | n/a+33.84% |
| Max drawdown | GNMX GNOM | -8.53%-8.57% | n/a-18.16% | n/a-43.10% | n/a-71.04% |
| Max drawdown duration | GNMX GNOM | 32d32d | n/a145d | n/a674d | n/a1817d |
Trading data
GNMX | GNOM | |
Last sale 9/10/2026 at 1:30 PM | $61.97 | |
| Previous close 09/10/2026 | $62.75 | |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
GNMX
is actively managed and doesn’t replicate an indexGNMX | GNOM | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/10/2026 at 1:30 PM
Live
Closed
GNMX | GNOM | |
|---|---|---|
| Last price | – | $61.97 |
| 1D performance | – | -1.25% |
| AuM | $2.54 M | $90.12 M |
| E/R | 0.35% | 0.5% |
Characteristics
GNMX | GNOM | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Corgi Funds | Global X |
| Benchmark | - | Solactive Genomics Index |
| N° of holdings | 57 | - |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | May 6, 2026 | April 5, 2019 |
| ESG | No | No |
Advertisement
Exposure
Countries
GNMX
USA
87.58%
Other
12.42%
GNOM
Data will be available soon
Sectors
GNMX
Healthcare
96.78%
Other
3.22%
GNOM
Data will be available soon
Advertisement
Diversification
GNMX
Total weight of top 15 holdings out of 15
55.56%
GNOM
Data will be available soon
Top 15 holdings
Data as of July 31, 2026
GNMX
Thermo Fisher Scientific, Inc.
9.28%
Vertex Pharmaceuticals, Inc.
6.75%
Illumina, Inc.
4.56%
Guardant Health, Inc.
4.26%
Revolution Medicines, Inc.
3.92%
Incyte Corp.
3.38%
Moderna, Inc.
3.06%
Genmab A/S
2.96%
Alnylam Pharmaceuticals, Inc.
2.77%
Bio-Techne Corp.
2.67%
10X Genomics, Inc.
2.58%
BioMarin Pharmaceutical, Inc.
2.55%
Arrowhead Pharmaceuticals, Inc.
2.34%
Krystal Biotech, Inc.
2.30%
QIAGEN NV
2.18%
GNOM
Data will be available soon
Frequently asked questions about GNMX and GNOM
Which ETF is bigger: GNMX or GNOM?
As of September 10, 2026, GNMX holds $2.54 M in assets under management (AUM), while GNOM manages $90.12 M.
Advertisement
Advertisement
